Aviance Capital Partners’s Idexx Laboratories IDXX Stock Holding History

Aviance Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$421K	Hold	750	–	–	0.05%	264
2025 Q4	$507K	Hold	750	–	–	0.06%	234
2025 Q3	$479K	Hold	750	–	–	0.06%	236
2025 Q2	$402K	Hold	750	–	–	0.05%	251
2025 Q1	$315K	Hold	750	–	–	0.04%	269
2024 Q4	$310K	Hold	750	–	–	0.04%	256
2024 Q3	$379K	Sell	750 -1	-0.1%	-$486	0.05%	247
2024 Q2	$366K	Buy	751 +1	+0.1%	+$502	0.05%	238
2024 Q1	$405K	Buy	+750	New	+$410K	0.06%	229

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Aviance Capital Partners's IDXX Position: Q1 2026 in Review

Aviance Capital Partners held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 750 shares worth $421K. The position accounts for 0.05% of the portfolio, ranked #264.

Aviance Capital Partners first reported a position in IDXX in Q1 2024 and has held it in 9 quarters since. The position peaked at $507K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Aviance Capital Partners held 750 shares of Idexx Laboratories worth $421K as of Q1 2026.
Aviance Capital Partners left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up 0.05% of Aviance Capital Partners's portfolio in Q1 2026, its #264 holding.
Aviance Capital Partners first reported a position in Idexx Laboratories in Q1 2024 and has held it in 9 quarters since.
Aviance Capital Partners's Idexx Laboratories position peaked at $507K in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Aviance Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.